Bulk Pharmaceutical API Sources for flurbiprofen sodium

Bulk Pharmaceutical API Sources for flurbiprofen sodium

Vendor	Vendor Homepage	Vendor Sku	API Url
BOC Sciences		56767-76-1
BLD Pharm		BD246768
Angel Pharmatech Ltd.		AG116255
Molport		MolPort-006-131-043
Debye Scientific Co., Ltd		DB-072190
Clearsynth		CS-T-54972

Bulk Active Pharmaceutical Ingredient (API) Sources for: Flurbiprofen Sodium

Last updated: July 29, 2025

---

Introduction

Flurbiprofen sodium, a non-steroidal anti-inflammatory drug (NSAID), is widely utilized for its analgesic, anti-inflammatory, and antipyretic properties. Its applications span multiple therapeutic areas, including ophthalmology, arthritis management, and postoperative pain. As demand grows, pharmaceutical manufacturers seek reliable API sources to ensure quality, consistency, and cost-effectiveness. This article provides a comprehensive overview of bulk API sources for flurbiprofen sodium, highlighting key manufacturers, geographic considerations, regulatory environments, and sourcing strategies vital for pharmaceutical enterprises.

---

Overview of Flurbiprofen Sodium

Flurbiprofen sodium is the sodium salt of flurbiprofen, chemically characterized by its propionic acid backbone (2-fluoro-α-methyl-4-biphenylacetic acid). Due to its potency and specificity, high-quality API sourcing is crucial to maintaining formulation efficacy and regulatory compliance. The API's synthesis involves multi-step chemical processes, often requiring stringent quality controls and purification steps.

---

Global API Manufacturers and Sources

1. Major API Producers in India

India remains a dominant hub for gastrointestinal and ophthalmic APIs, including flurbiprofen sodium. Major Indian companies active in API manufacturing include:

• Sun Pharmaceutical Industries Ltd.
  Recognized for extensive API manufacturing capabilities, with certifications such as US FDA and EUGMP, Sun Pharma supplies flurbiprofen sodium to global markets.

• Lupin Limited
  With a broad product portfolio, Lupin offers high-quality APIs, including NSAIDs. The company's API facilities adhere to rigorous quality standards, meeting international regulatory requirements.

• Torrent Pharmaceuticals
  Known for their integrated R&D and manufacturing, Torrent supplies bulk flurbiprofen sodium with GMP compliance.

• Granules India
  Focused on cost-effective API production, Granules India is a reliable supplier with a focus on compliance and scalability.

2. Chinese API Manufacturers

China’s API sector is expanding rapidly, leveraging cost advantages and scalability.

• Zhejiang Hisun Pharmaceutical Co., Ltd.
  An established manufacturer offering flurbiprofen sodium APIs, with an emphasis on quality certifications similar to ISO, GMP, and CE.

• Shandong Xinhua Pharmaceutical Co., Ltd.
  Known for integrating R&D with manufacturing, Xinhua supplies APIs to global pharmaceutical firms, emphasizing regulatory compliance.

• Shenzhen Qianhai Pharmaceutical Co., Ltd.
  Focused on bulk NSAIDs, Qianhai delivers flurbiprofen sodium with competitive pricing and regulatory adherence.

3. European and North American Suppliers

Although fewer in number compared to Asia, some European and North American manufacturers meet the highest standards of quality:

• BASF (Germany)
  As a leading global chemical and pharmaceutical ingredient producer, BASF offers custom synthesis and high-purity APIs, including flurbiprofen sodium, predominantly for specialized markets.

• Alfa Aesar (USA)
  As part of Thermo Fisher Scientific, Alfa Aesar supplies research-grade and pharmaceutical-grade APIs, including flurbiprofen sodium, with traceability and documented purity.

• Sagent Pharmaceuticals (USA)
  Specializing in sterile and injectable formulations, Sagent sources bulk APIs with strict GMP supervision.

---

Sourcing Strategies and Considerations

Regulatory Compliance & Certifications

For pharmaceutical companies, selecting API sources hinges significantly on regulatory compliance. Manufacturers must ensure suppliers possess necessary certifications—including US FDA Drug Master Files (DMF), European Medicines Agency (EMA) approval, and good manufacturing practices (GMP). These assure product quality, traceability, and regulatory acceptance.

Quality Assurance & Purity Standards

High API purity (>99%) and low impurity levels are mandated by international guidelines. Suppliers should provide Certificates of Analysis (CoA), stability data, and validated manufacturing processes.

Cost and Supply Stability

Cost competitiveness is crucial, especially for high-volume manufacturing. Asian suppliers often offer lower prices owing to economies of scale, but supply chain stability, lead times, and geopolitical issues must be assessed.

Environmental and Ethical Standards

Manufacturers adhering to environmental regulations and ethical sourcing provide added assurance of sustainable practices, aligning with corporate social responsibility policies.

---

Emerging Trends and Challenges

1. API Market Consolidation

The API market is witnessing consolidation, with large players expanding capabilities through acquisitions or partnerships. This trend enhances quality control but also influences pricing dynamics.

2. Regulatory Stringency

Evolving global regulatory standards demand rigorous validation processes, complicating sourcing but ensuring higher safety and efficacy standards. Manufacturers must maintain strict compliance to sustain market access.

3. Supply Chain Disruptions

Breaches in supply chains, exemplified during the COVID-19 pandemic, underscore the necessity of diversified sourcing options, multiple supplier tiers, and geographic spread to mitigate risks.

4. Custom Synthesis and Innovation

There is increasing demand for tailored APIs with optimized bioavailability and reduced impurities. Companies investing in R&D offer differentiated sourcing options through custom synthesis.

---

Conclusion and Recommendations

Securing a reliable, high-quality source for flurbiprofen sodium API requires balancing regulatory compliance, quality standards, cost, and supply chain robustness. Entities should prioritize suppliers with proven GMP certification, transparent quality documentation, and a track record of regulatory compliance in target markets. It is advisable to establish multi-source strategies, vet suppliers through audits, and regularly monitor the evolving regulatory landscape to ensure continuous supply and compliance.

---

Key Takeaways

• Indian and Chinese manufacturers dominate the bulk API supply chain for flurbiprofen sodium, offering cost-effective options with varying degrees of regulatory approval.
• High-quality sourcing necessitates strict adherence to GMP standards, regulatory certifications, and verified purity levels.
• Diversification and supplier vetting mitigate risks from geopolitical and supply chain disruptions.
• Staying current with regulatory changes and technological innovations enhances sourcing strategy efficacy.
• Building strong, transparent relationships with suppliers accelerates quality assurance and compliance efforts.

---

FAQs

1. What are the primary considerations when sourcing flurbiprofen sodium API globally?
Regulatory compliance (GMP certification), purity standards, cost, supply chain reliability, and supplier reputation are fundamental factors.

2. Which countries are the top producers of flurbiprofen sodium API?
India and China lead global production, with significant contributions from Europe and North America for specialty or high-purity APIs.

3. How can pharmaceutical companies verify the quality of their API suppliers?
Perform supplier audits, review Certificates of Analysis, validate GMP certification, and maintain ongoing quality assessments.

4. What regulatory certifications should API suppliers possess for international markets?
US FDA DMF, EMA certifications, GMP compliance, ISO certifications, and other relevant regional approvals.

5. Are there any trends influencing future API sourcing for NSAIDs like flurbiprofen sodium?
Yes. Increasing regulatory stringency, supply chain diversification, environmental considerations, and advances in custom synthesis are shaping future sourcing strategies.

---

Sources

[1] Pharma sources and industry reports, 2022-2023.
[2] Indian Pharmaceutical Alliance. "API Manufacturing Capabilities." 2022.
[3] Chinese API Sector Overview, China Pharmaceutical Industry Association. 2022.
[4] European Medicines Agency (EMA). "Guidelines on API Quality." 2021.
[5] BASF official website. "High-Quality APIs for Pharmaceuticals." 2023.